| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |